| ADR Ontology |
| ADR Term |
Pulmonary sarcoidosis |
| ADR ID |
BADD_A07621 |
| ADR Hierarchy |
|
| Description |
Sarcoidosis affecting predominantly the lungs, the site most frequently involved and most commonly causing morbidity and mortality in sarcoidosis. Pulmonary sarcoidosis is characterized by sharply circumscribed granulomas in the alveolar, bronchial, and vascular walls, composed of tightly packed cells derived from the mononuclear phagocyte system. The clinical symptoms when present are dyspnea upon exertion, nonproductive cough, and wheezing. (Cecil Textbook of Medicine, 19th ed, p431) [MeSH] |
| MedDRA Code |
10037430 |
| MeSH ID |
D017565
|
|
ADR Severity Grade (FAERS)
|
|
|
ADR Severity Grade (CTCAE)
|
Not Available
|
| Synonym |
| Lung sarcoid | Pulmonary sarcoidosis | Sarcoidosis, Pulmonary | Pulmonary Sarcoidosis | Pulmonary Sarcoidoses | Sarcoidoses, Pulmonary |
|
|
| ADR Related Proteins |
| Protein Name |
UniProt AC |
TTD Target ID |
| Not Available | Not Available | Not Available |
|
| Drugs Leading to the ADR |
|
|
